THE MERCK VETERINARY MANUAL
Print Topic

Sections

Chapters

Metabolic Diseases Affecting the Liver in Small Animals

-
-

Diabetes mellitus, hyperadrenocorticism, hypothyroidism, and hyperthyroidism can cause changes in the liver.

HL can develop secondary to diabetes mellitus because of increased lipid metabolism and mobilization; notable are hepatomegaly and increased liver enzyme activities. Dogs with diabetes mellitus rarely manifest liver dysfunction unless they develop severe progressive VH associated with the hepatocutaneous syndrome (see Hepatocutaneous Syndrome in Small Animals). Most of these dogs have markedly increased ALP with lesser increases in transaminase activity. Diabetic cats also may develop increased ALT and ALP activities and may become hyperbilirubinemic with onset of HL. Diabetic animals have increased risk of pancreatitis that may progressively lead to EHBDO and cholangitis. These animals have increased risk of bacterial infections involving biliary structures (emphysematous cholecystitis, cholangitis).

Cats with hyperthyroidism usually develop increases in ALP and ALT activities and are rarely hyperbilirubinemic. Liver function is usually normal. The underlying cause of altered enzyme activity is not fully understood but postulated to involve toxic effects of excessive thyroxine, malnutrition, cardiac dysfunction, induction phenomenon, and increased bone turnover (causing increase in the bone isoenzyme of ALP). Liver enzymes return to normal with successful treatment; however, methimazole also can lead to a drug-associated hepatopathy that resolves only after drug discontinuation.

Last full review/revision May 2015 by Sharon A. Center, BS, DVM, DACVIM

Copyright     © 2009-2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A.    Privacy    Terms of Use    Permissions